Southeast Minnesota Capital Partners

Southeast Minnesota Capital Fund supplies crucial early-stage investment capital to Minnesota entrepreneurs developing innovative, high-growth companies. The fund primarily targets seed and early-stage opportunities within the med tech and life science sectors, seeking out firms with groundbreaking technologies and products. It employs a strategic investment approach, engaging its members, many of whom have deep experience from Mayo Clinic, to evaluate potential portfolio companies and leverage their collective expertise.

The fund was established in 2017 by Rochester Area Economic Development Inc. (RAEDI) executives Gary Smith and Xavier Frigola. Their foundational insight stemmed from the 2014 "Journey to Growth" regional economic development plan, which identified a pronounced need for dedicated local equity capital to support emerging innovative businesses across Southeast Minnesota. This initiative aimed to bridge a critical financing gap for early-stage ventures in the region.

Southeast Minnesota Capital Fund serves Minnesota-based companies, with a preference for those situated in or linked to Rochester and the Mayo Clinic ecosystem. The fund's overarching vision is to generate significant returns for its members through successful investments. Concurrently, it actively contributes to fostering regional economic development, with an aspiration to cultivate Rochester into a prominent bio-business hub, driving long-term growth and innovation.